Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

SHA:688739 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,894	10,612	13,539	12,668	31,704	-
Market Cap Growth	-1.51%	-21.62%	6.87%	-60.04%	-	-
Enterprise Value	5,836	5,273	7,974	7,019	29,988	-
Last Close Price	26.49	25.01	30.57	27.77	68.12	-
PE Ratio	61.48	30.96	29.06	17.74	35.52	-
Forward PE	27.59	23.60	18.60	-	-	-
PS Ratio	7.41	6.33	7.74	6.98	15.18	-
PB Ratio	1.16	1.11	1.41	1.31	3.39	-
P/TBV Ratio	1.18	1.13	1.44	1.34	3.44	-
P/FCF Ratio	413.55	76.63	108.30	363.13	-	-
P/OCF Ratio	28.61	21.18	20.00	23.18	62.61	-
EV/Sales Ratio	3.97	3.15	4.56	3.87	14.36	-
EV/EBITDA Ratio	14.88	9.59	12.76	8.24	27.24	-
EV/EBIT Ratio	30.90	13.71	15.80	9.55	30.29	-
EV/FCF Ratio	221.55	38.08	63.79	201.20	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	-
Debt / EBITDA Ratio	0.03	0.03	0.03	0.03	0.02	-
Debt / FCF Ratio	0.46	0.11	0.16	0.63	-	-
Asset Turnover	0.15	0.17	0.17	0.18	0.29	0.49
Inventory Turnover	0.71	0.72	0.76	0.56	0.66	1.04
Quick Ratio	19.07	16.73	19.05	26.38	25.52	11.76
Current Ratio	20.69	18.01	20.32	28.23	26.98	13.32
Return on Equity (ROE)	1.88%	3.58%	4.84%	7.51%	13.25%	24.35%
Return on Assets (ROA)	1.19%	2.39%	3.13%	4.63%	8.67%	14.85%
Return on Invested Capital (ROIC)	1.24%	2.50%	3.27%	4.82%	9.17%	16.17%
Return on Capital Employed (ROCE)	2.00%	4.00%	5.20%	7.50%	10.40%	23.00%
Earnings Yield	1.63%	3.23%	3.44%	5.64%	2.81%	-
FCF Yield	0.24%	1.31%	0.92%	0.27%	-0.01%	-
Dividend Yield	3.02%	3.20%	2.62%	3.60%	1.47%	-
Payout Ratio	185.04%	96.08%	89.35%	58.30%	-	24.49%
Buyback Yield / Dilution	-0.26%	0.71%	0.37%	-9.48%	-1.77%	0.18%
Total Shareholder Return	2.76%	3.91%	2.99%	-5.88%	-0.30%	0.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.